Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxSelling, General & AdministrativeWages, Salaries and Other
Others
Ratios

Nu-Med Plus (NUMD) Depreciation & Amortization - Total (2016 - 2022)

Nu-Med Plus' Depreciation & Amortization - Total history spans 10 years, with the latest figure at $2650.0 for Q4 2021.

  • On a quarterly basis, Depreciation & Amortization - Total changed 0.0% to $2650.0 in Q4 2021 year-over-year; TTM through Dec 2021 was $9365.0, a 20.6% decrease, with the full-year FY2021 number at $9365.0, down 20.6% from a year prior.
  • Depreciation & Amortization - Total hit $2650.0 in Q4 2021 for Nu-Med Plus, roughly flat from $2649.0 in the prior quarter.
  • Over the last five years, Depreciation & Amortization - Total for NUMD hit a ceiling of $3803.0 in Q2 2018 and a floor of $1417.0 in Q2 2021.
  • Historically, Depreciation & Amortization - Total has averaged $3090.6 across 5 years, with a median of $3091.0 in 2019.
  • Biggest five-year swings in Depreciation & Amortization - Total: soared 100.67% in 2017 and later tumbled 53.51% in 2021.
  • Tracing NUMD's Depreciation & Amortization - Total over 5 years: stood at $3585.0 in 2017, then grew by 5.27% to $3774.0 in 2018, then decreased by 19.55% to $3036.0 in 2019, then fell by 12.71% to $2650.0 in 2020, then changed by 0.0% to $2650.0 in 2021.
  • Business Quant data shows Depreciation & Amortization - Total for NUMD at $2650.0 in Q4 2021, $2649.0 in Q3 2021, and $1417.0 in Q2 2021.